Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.

RD, Inman; JC Jr, Davis; Dv, Heijde; L, Diekman; J, Sieper; SI, Kim; M, Mack; J, Han; S, Visvanathan; Z, Xu; B, Hsu; A, Beutler; J, Braun

doi:10.1002/art.23969

Public

Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.

Shared by NobleBlocks on Nov 1, 2008 • 12:00 AM UTC

Authors:

Inman RD

Davis JC Jr

Heijde Dv

Abstract

<h4>Objective</h4>To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO-RAISE study.<h4>Methods</h4>Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score > or =4, and a back pain score of > or =4 were randomly assigned in a 1.8:1.8...

Discussions